World Health Organization site
Skip Navigation Links

Main
Note: This record shows only the 20 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 17 October 2012
Main ID:  NCT00121160
Date of registration: 13/07/2005
Primary sponsor: Fred Hutchinson Cancer Research Center
Public title: Health SMART (Stress Management and Relaxation Training) to Improve Vaccine Immune Response
Scientific title: Can Stress Management Improve Vaccine Immune Response
Date of first enrolment: September 2005
Target sample size: 126
Recruitment status: Completed
URL:  http://clinicaltrials.gov/show/NCT00121160
Study type:  Interventional
Study design:  Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Prevention  
Countries of recruitment
United States
Contacts
Name:   Bonnie A. McGregor, PhD
Address: 
Telephone:
Email:
Affiliation:  Fred Hutchinson Cancer Research Center
Key inclusion & exclusion criteria

Inclusion Criteria:

- Female, age 18-60 years

- Family history of breast cancer

- Fluent in English

- Working phone

- Working address

- Plan to live in the area for one year

Exclusion Criteria:

- Prior cancer diagnosis (except non-melanoma skin cancer)

- Current major depressive episode

- History of Bipolar Disorder or Schizophrenia

- History of autoimmune disease

- History of Hepatitis A or HA vaccination

- Current infectious disease

- Use of immune modulating drugs



Age minimum: 18 Years
Age maximum: 60 Years
Gender: Female
Health Condition(s) or Problem(s) studied
Psychological Stress
Intervention(s)
Behavioral: Cognitive Behavioral Stress Management (CBSM) group intervention
Primary Outcome(s)
Independent sample t-test will be used to compare 1) antibody change scores from before to after the first and second dose of vaccine, and 2) distress change scores from before to after the intervention [Time Frame: length of protocol]
Secondary Outcome(s)
Multiple regression analyzes will be used to test changes in cortisol and changes in perceived risk of breast cancer; coping or social support mediate the effects of the intervention on antibody response to vaccine and distress [Time Frame: length of protocol]
Secondary ID(s)
IRB-6003
NCI-K01-CA107085-01
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
National Cancer Institute (NCI)
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.1 - Version history